'Chinese doctors have come to the world, domestic patients are time to stop the footsteps of foreign treatment!' Chinese Academy of Medical Sciences Fu Wai Hospital, director of Cardiology Yao Yan said.Although the overall quality of medical treatment in the ranking, not top in the world, but for Many areas of major disease treatment, especially heart disease, organ transplantation, neurological diseases, blood diseases and other fields, the domestic diagnosis and treatment technology are already in the world's leading level.
Atrial fibrillation patients to be anti-push back abroad
Surgery prices are 10 times the domestic
'Last year, a retired veteran came to me for an operation and asked me if I knew why he found me,' said Yao Yan, MD, of Fuwai Hospital, Chinese Academy of Medical Sciences. 'This patient told me it was because he went to the United States, Where the white doctor recommended to return to China to find me, he decided to return to China to find me.
Atrial fibrillation is the abbreviation of atrial fibrillation, which is one of the most common arrhythmia.As the age increases, the incidence of atrial fibrillation continues to increase, up to 10% of the population over the age of 70.
"For Beijing, Fu Wai Hospital and Ahn Jung Hospital are the largest and second largest heart treatment centers in the world, both in technology and equipment, and are world class." For almost 30 years of AF treatment Yao Yan, the domestic atrial fibrillation surgery in the world are 'first class'.
Since 2007, Fuwai Hospital of Chinese Academy of Sciences has conducted special advanced training in arrhythmia training for experts from all over the world.The photo shows Yao Yan (second from right), Director of Cardiology, Fuwai Hospital, Chinese Academy of Sciences, and a group of well-known British doctors for AF treatment. Fu Wai Hospital for the map
Yao Yan told reporters that atrial fibrillation in the domestic treatment of catheter ablation costs an average of 90,000 yuan or less, but the median US hospital is 90,000 US dollars, high-priced hospitals can even reach 150,000 US dollars, the conversion rate is the domestic 6 to 10 times, this is only the hospital charge for treatment, if the cost of the journey, accommodation, intermediary and other costs are all included, the total cost of more than ten times in the country, in addition to the price is unreasonable, the surgical follow-up process is also Will be embarrassed: 3 months after surgery follow-up observation, adjustment and late guidance, only in foreign surgery, is not enough.
Nowadays some families easily go abroad to do common diseases and often dozens or even millions. Even more sadly, patients do not realize that the same treatment level can be achieved in China only by tens or even less.
In addition, Yao Yan also made a comparison between AF surgery in Hong Kong and Hong Kong. Private hospitals in Hong Kong attracted many patients. In fact, the operation volume of many private hospitals in one year is often not as good as that of a doctor in a large hospital in the Mainland , And the cost of surgery in Hong Kong is about several hundred thousand Hong Kong dollars, which is also several times higher than that of mainland hospitals. Some people say that the large amount of surgery does not mean that the quality is high, of course, there is some truth. However, In terms of the experience of complex and difficult cases involving 1.3 billion people and the best equipment and international academic exchange platform, this argument is untenable in most cases. In fact, according to the Fu Wai Hospital Cardiac Surgery Director Zheng Zhe's big data published in authoritative academic journals in the international heart field showed that the surgical mortality rate of Fu Wai Hospital reached or even surpassed that of the top cardiac centers in the United States, for example, in coronary artery bypass graft surgery.
The total number of kidney transplants ranks second in the world
Some hospitals have a five-year survival rate of 85%
Before I came to Beijing for inspection, my parents had been raising money and wanted to send me abroad for kidney transplantation. "Sun Chao, a kidney transplant recipient from Jidong County, Jixi City, Heilongjiang Province, told reporters that it was completely unnecessary after that.
Sun Chao is now the first 5 years after surgery, although his family did not dare to let him work, but drove her daughter to school every day in the store selling goods has no problem.
There are well-known experts from the United States who shared the same feelings with the Sun. 'Before China came to China, it did not think that China had reached the same level of kidney transplant as the United States and wanted to establish long-term ties with the Chinese team. Hopefully, China The video of the surgery for urology can be played and communicated at the American Society for Organ Transplantation next year (2018). "As one of the nation's most prominent kidney transplant surgeons and also the forthcoming President of the American Society for Organ Transplantation 2018 Matthew Cooper, speaking to Fieldland Urology, Beijing Friendship Hospital affiliated to Capital Medical University, said in a visit to China in 2017.
In the meantime, Dr. Cooper also showed great interest in the many improvements made by urology for nephrectomy when he visited Beijing.
He believes that China's technology has obvious advantages in terms of vascular treatment, prevention of complications and shortening of warm ischemia time compared with the technologies commonly used in the major transplant centers in the United States.
If not, the famous U.S. experts say that perhaps many people are still not aware that China's kidney transplant has reached a world-leading level in recent years with its rapid development.
Ren Ren Hospital of Renal Transplant Center, director of China Association of transplant transplant committee Zhang Ming told reporters that although the history of kidney transplant in China can be traced back to half a century ago, but more Chinese people on the local kidney transplant technology awareness still Stay in the initial stage of development, which is why our technology has reached the world advanced level, but there are still patients 'Zaguomaitie' reasons for going abroad surgery.
To help journalists better understand the current status of kidney transplantation in China, Zhang gives a set of data: as of the end of 2017, only 1,800 kidney transplantations have been carried out in only one transplant center of Renji Hospital affiliated to Shanghai Jiao Tong University, of which living relatives Between the kidney kidney transplantation for 180 cases.Zhang Ming director introduced organ donation is not only an important symbol of the development of medical technology, but also a manifestation of social civilization and progress.With the formation of the voluntary environment in China's voluntary organ donation, China will have More and more patients with end-stage organ failure recover from the advanced technology of transplantation.
For the renal transplant recipients are very concerned about postoperative graft survival time, Zhang said that this indicator has reached the advanced international level to Shanghai Renji Hospital, for example, kidney transplant recipients one year after surgery with kidney Healthy survival rate of 95% or more, five-year renal transplant survival rate of over 83%, 10-year survival rate of 75% With the deepening understanding of renal transplant rejection mechanism, the continued progress of immunosuppressive therapy, and missionary work made With the progress of patients with higher and higher degree of cooperation can be expected in the future long-term survival of graft kidney will be higher and higher.
According to the official statistics of WHO and China's kidney transplant scientific registration system, the number of kidney transplants in 2016 (living donation + donation after death): the top one is the United States, 19858 cases are completed; the second is China, completed 9019 cases, and China is the only Asian country in the world with the top five cases of kidney transplant (third in Brazil, fourth in France, fifth in fifth and Turkey in Turkey).
Pediatric congenital biliary atresia into a strong item
New liver transplantation technology to the world
'Mom, I love you, do not throw me down.' 9-year-old fat (a pseudonym) after a one-time vomiting blood 500 ml, cried to her mother said.
Fat is a girl with congenital biliary atresia, after trying all kinds of conservative treatment, the condition is deteriorating, the first time I saw the reporter, the hands kept fat doll keep fat, white fat skin Childlike eyes make people think that such a beautiful face and how it will not be associated with this cruel disease, but then, fat is already waiting for a suitable liver transplant patients.
A few months later, the fat mother sent a text message to the Health Times reporter: The operation succeeded! The fat has been transferred from the intensive care unit to the general ward.
The reporter recently re-linked to the fat mother, the message is: fat has returned to school, the world did not give up her.
Speaking of this child returned to the beautiful world after nine years of struggle, but also due to the rapid development of the domestic congenital treatment of biliary atresia - liver transplantation.
According to incomplete statistics, there are nearly 3,000 children in China each year, with more than 90% mortality due to various congenital diseases resulting in end-stage liver cirrhosis of infants and young children. Among them, the most common congenital biliary atresia, due to the bile duct 'solid' , Bile can not be discharged, resulting in irreversible liver damage in children.If there is no active and effective treatment, 90% of them will be within 1 year of age due to liver failure and death, the only way of diagnosis and treatment is liver transplantation.
As the past 6 years, the world's largest hospital for children undergoing liver transplantation surgery, Renji Hospital, Shanghai Jiao Tong University, vice president, director of liver surgery Xia Qiang, told reporters a set of figures: the hospital children after one year of liver transplantation survival rate of up to 93%, 5-year survival rate of 80% .At present China's annual liver transplant surgeries in children in the United States surpassed 2/3 of the same type of surgery in the United States, Europe, the amount of liver transplantation in children.
Such a set of data, is the biliary atresia, pediatric liver transplantation, the most powerful evidence.
In fact, in addition to child liver transplantation, China's adult liver transplantation has also reached the world's most advanced ranks.
Zhu Zhijun, director of the Liver Transplantation Center at Beijing Friendship Hospital, said that in recent years, the incidence of liver cancer in China has been increasing year by year, accounting for 55% of the global liver cancer in China, which is very large. As of 2016, there are still 90 million chronic hepatitis B patients in China, of which 700 Thousands of people need emergency treatment due to the risk of serious liver disease and cancer, and for patients with end-stage liver disease, liver transplantation is the only way to prolong life.
In our country, the number of liver transplantation continues to increase, while the survival rate of patients after liver transplantation has also been steadily increased.Many major liver transplant centers in China at 5 years after liver transplantation survival rates have reached more than 70%.
Talking about his new peer-reviewed liver transplantation technology, "Mino-assisted liver transplantation," Zhu Zhijun told reporters that due to liver tension, doctors save people due to eagerness to do a lot of new attempts, and gradually became a new technology, continue to get The world's recognition.
'In the summer of 2017, I have been attending various lectures on liver transplantations abroad to introduce this new technology to the world.' To better enable journalists to understand the principles of this 'mysterious new technology,' Zhu Zhijun picks up paper at the desk The procedure was portrayed: both patients were waiting for liver replacement, one because the liver could not secrete A and caused A1 disease, and the other was because the liver could not secrete B and caused B1 disease, and neither patient's condition was no longer available Wait a second, I cut the liver of each patient in half and swapped.
So each patient's body has half of his own liver and half of each other from the liver, they can secrete A and B secretion, there will be no A1 disease and B1 disease.
Facts have proved that the operation was successful.
Zhu Zhijun pointed to the only pendant in his office - the embroidery on the wall saying that this was one of the patients who had accepted liver exchange at that time and did the hand embroidery after the successful operation.
Heart valve treatment world leader
Foreign valves may not be suitable for Chinese
The human heart has four valves, namely the mitral valve, the tricuspid valve, the aortic valve and the pulmonary valve, the heart valve thin as paper, when the valve stenosis, closed incomplete, the heart shape will change, leading to myocardial Hypertrophy, atrial or (and) ventricular enlargement, cardiac contractile function decline, the final pump failure. 'Many patients in the diagnosis of valvular heart disease, the first reaction is to go abroad, that foreign advanced technology, surgery will do Be more meticulous and secure. 'Wang Fang, director of Cardiology, Beijing Hospital, said in fact, since 2014, China's heart valve treatment has been the world leader.
June 3, 2014, academician of Chinese Academy of Engineering, Fu Wai Hospital, Department of Cardiology chief expert Gao Runlin and vice president of Fuwai Hospital, the National Center for Clinical Research of Cardiovascular Diseases Yang Yuejin together announced that China's first clinical application of valvular valve disease The first successful test, which also marks the advent of valvular heart disease in our country by catheterization.
"Compared with 20 years ago, the cause of heart valve disease in China has undergone tremendous changes in the composition of the vast majority of patients before are rheumatic heart disease." Yang Yuejin, vice president of introduction, and now adult surgical ward patients with valvular disease are mostly elderly Degenerative valvular disease, often varying degrees of heart valve stenosis and insufficiency routine valvular therapy is a thoracotomy, resection of the damaged valve and implantation of a new artificial valve, the patient's heart must stop beating, the risk is high, Many patients therefore lose the chance of surgery, while China's latest aortic valve replacement is a minimally invasive, lower cost than the import of 1/3, which is of great significance for the aging of China.
Three years later, in 2017, China also reported a good news in the field of valvular heart disease.Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine successfully completed the transapical TAVI operation after the first domestic J-Valve valve was introduced.Renji Hospital of Shanghai Jiao Tong University Xue Song, director of cardiovascular surgery in an interview, said patients with aortic valve insufficiency can not be completed by other path TAVI surgery, apical route is the only surgical path.
'At present, TAVI surgery is an internationally advanced and leading technology in China. Through a small catheter during operation, there is no need for chest incision and no need for extracorporeal circulation to minimize trauma and reduce the risk of surgery. "Xue Song told reporters that due to the avoidance of Traditional thoracotomy, cardiopulmonary bypass and cardiac arrest, and therefore for patients who can not tolerate traditional cardiac surgery is particularly applicable.At present, the treatment of high-risk aortic stenosis abroad mainstream method can be completed without pressure in the country, the heart valve Patients can do world-class surgery at your doorstep!
In addition, 'our country's blood vessels in patients with walking and organ size and so are not suitable for foreign valves.' In addition to our doctors in the world's leading surgical technology, Wang Fang talked about heart valve patients abroad surgery is also very worried that many foreign equipment Not suitable for Chinese patients.
Governance glioma domestic impeccable
God outside the big coffee ran the world spread of medicine
'At present, all diseases in the field of neurosurgery are not necessary to go abroad.' 'Zhang Guogang, vice president of Xiangya Hospital of Central South University, said proudly when talking about the development of neurosurgery in China. Now 301 hospitals, Tiantan Hospital, Xiangya Hospital, etc. Many top three hospital experts have gained a very high status worldwide.
Professor Roy Colven, Department of Dermatology, University of Washington (first from right) waited until visit and exchange at Xiangya Hospital of Central South University.
Speaking of this, I have to say that China's neurological intervention Lingfeng Ling'.Zhang Guogang mentioned, Capital Medical University Xuanwu Hospital, director of neurosurgery Ling Feng, has repeatedly in the world conference of neurosurgical and nerve interventional radiology conference Do a special report, and was invited to France, the United States, Germany, Japan and other countries to give lectures.
In the field of neurosurgery, there are still many experts who will attract many foreign experts to study after they have been abroad. Many international conferences of neurosurgery specialize in the operation of videos of surgery outside our own fields. Whether it is academic achievement or international prestige, the domestic patients There is no reason to go far.
Brain stem glioma is the most complex and highly heterogeneous disease in brain tumors, and remains the most significant tumor with the highest morbidity, mortality and recurrence in brain tumors.
Fluorescence microscopy, ultrasound scalpel, intraoperative MRI, gamma knife, these means not only to diversify the treatment of glioma in China, but also let the lingering in the patient's cancer nearly four hundred years no longer be ' Black 'flooded.
In February 2016, Clinical Cancer Research, a well-known clinical journal of the American Association for Cancer Research, published a pioneering study by the Mao Ying team of the Department of Neurosurgery at Huashan Hospital, which shows that the medical costs due to brain diseases are about to reach 10% of global GDP, Become the biggest medical burden, but also our country now facing major health problems.
In the past ten years, with the innovative development of microsurgical techniques and devices, the widespread application of multimodal fusion technology, as well as neuroimaging, neuro-navigation techniques, intraoperative MRI and ultrasound imaging, tumor intraoperative fluorescence imaging , Multi-lead neural electrophysiological monitoring technology continues to progress and development of surgical safety and resection of brain stem glioma has made significant progress.
'Looking back, our neurosurgery also has nearly a hundred years of history,' Zhang Guogang said in an interview with reporters that the current application of precision medicine in neurosurgery has more basis and technical support, such as molecular imaging changed The pathological understanding of brain tumors; surgical robots, intraoperative navigation and minimally invasive surgical technology innovation and development of surgical treatment of brain tumors more accurate.Multimodality technology is widely used to brain stem glioma preoperative assessment, Intraoperative treatment more accurate, less damage to neurological function, quality of life better.
With all kinds of brand-new treatments in our country constantly being respected by the world, competing for study; all kinds of instruments are accepted all over the world, being used and reported in succession; experts and scholars of various hospitals went to the forefront of bringing Chinese medicine to the world , And worked tirelessly, domestic patients no longer no reason to no longer believe in the development of medical care in the motherland.
As Yao Yan said, Chinese doctors have already gone to the world. It is time for the patients in China to stay.
Reference material
① Chinese kidney transplant scientific registration system.
② International kidney transplant data source from the International Donor and Transplantation data observation system.
③ PININDM, BRAYF, FERLAYJ, et al. Estimating the World cancer burden: globocan2000'J '. IntJ Cancer, 2001, 94 (2): 153-156.
④ On July 28, 2016, World Health Organization released its annual hepatitis data on World Hepatitis Day and involved the data of China. It came from the public coverage returned by the Xinhua News Agency Geneva Branch reporter on the same day.
⑤Yao Y, Ye H, Qi Z, et al. B7-H4 (B7x) -Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6 / JAK / STAT3 Pathway to Poor Prognosis in Glioma Patients. 'J'. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 2016, 22 (11): 2778.
⑥ Mao Ying, Cai Jiajun, Yao Yu. Status and Prospects of Brain Stem Glioma 'J'. Chinese Journal of Neurosurgical Diseases, 2015, 14 (2): 97-100.
